Greatmark Investment Partners Cut Carbo Ceramics (CRR) Stake; Arrowpoint Asset Management Has Boosted By $5.22 Million Its Endologix (ELGX) Position

April 17, 2018 - By Michael Leger

CARBO Ceramics Inc. (NYSE:CRR) Logo

Arrowpoint Asset Management Llc increased Endologix Inc (ELGX) stake by 11.8% reported in 2017Q4 SEC filing. Arrowpoint Asset Management Llc acquired 1.04M shares as Endologix Inc (ELGX)’s stock declined 17.89%. The Arrowpoint Asset Management Llc holds 9.89 million shares with $52.91M value, up from 8.85M last quarter. Endologix Inc now has $340.76M valuation. The stock decreased 0.97% or $0.04 during the last trading session, reaching $4.07. About 534,361 shares traded. Endologix, Inc. (NASDAQ:ELGX) has declined 41.08% since April 17, 2017 and is downtrending. It has underperformed by 52.63% the S&P500.

Greatmark Investment Partners Inc decreased Carbo Ceramics Inc (CRR) stake by 68.05% reported in 2017Q4 SEC filing. Greatmark Investment Partners Inc sold 34,025 shares as Carbo Ceramics Inc (CRR)’s stock declined 26.06%. The Greatmark Investment Partners Inc holds 15,975 shares with $163,000 value, down from 50,000 last quarter. Carbo Ceramics Inc now has $229.45 million valuation. The stock increased 2.45% or $0.2 during the last trading session, reaching $8.37. About 319,647 shares traded. CARBO Ceramics Inc. (NYSE:CRR) has declined 36.43% since April 17, 2017 and is downtrending. It has underperformed by 47.98% the S&P500.

Among 10 analysts covering Endologix Inc. (NASDAQ:ELGX), 3 have Buy rating, 1 Sell and 6 Hold. Therefore 30% are positive. Endologix Inc. had 46 analyst reports since August 4, 2015 according to SRatingsIntel. On Thursday, August 17 the stock rating was maintained by Canaccord Genuity with “Hold”. The rating was upgraded by BTIG Research to “Buy” on Monday, September 28. BMO Capital Markets maintained the stock with “Hold” rating in Tuesday, December 12 report. The rating was downgraded by JP Morgan on Wednesday, November 16 to “Neutral”. The firm has “Overweight” rating given on Monday, April 4 by JP Morgan. RBC Capital Markets maintained it with “Outperform” rating and $17 target in Monday, June 13 report. RBC Capital Markets maintained Endologix, Inc. (NASDAQ:ELGX) rating on Tuesday, February 23. RBC Capital Markets has “Outperform” rating and $11 target. The rating was maintained by Oppenheimer on Thursday, August 3 with “Hold”. The rating was maintained by BMO Capital Markets with “Hold” on Monday, June 19. As per Tuesday, November 3, the company rating was maintained by Piper Jaffray.

Arrowpoint Asset Management Llc decreased Wal (NYSE:WMT) stake by 50,000 shares to 145,000 valued at $14.32M in 2017Q4. It also reduced Marathon Pete Corp (NYSE:MPC) stake by 63,100 shares and now owns 11,900 shares. Charter Communications Inc N was reduced too.

Investors sentiment increased to 1.1 in Q4 2017. Its up 0.03, from 1.07 in 2017Q3. It improved, as 13 investors sold ELGX shares while 26 reduced holdings. 16 funds opened positions while 27 raised stakes. 87.08 million shares or 4.75% more from 83.13 million shares in 2017Q3 were reported. Sg Americas Limited Liability Co accumulated 0% or 15,149 shares. Partner Mgmt Lp invested in 91,644 shares. Ameritas has invested 0% in Endologix, Inc. (NASDAQ:ELGX). Principal Financial Grp Inc has invested 0% in Endologix, Inc. (NASDAQ:ELGX). First Republic Mngmt Incorporated holds 10,993 shares. Vanguard Gp reported 6.89M shares stake. Jpmorgan Chase And holds 0% of its portfolio in Endologix, Inc. (NASDAQ:ELGX) for 52,895 shares. Blackrock holds 5.09M shares. Tower Limited Liability Company (Trc) has invested 0% in Endologix, Inc. (NASDAQ:ELGX). Wells Fargo & Mn stated it has 97,554 shares or 0% of all its holdings. Bank & Trust Of Montreal Can owns 0% invested in Endologix, Inc. (NASDAQ:ELGX) for 2,340 shares. Great West Life Assurance Co Can has 0% invested in Endologix, Inc. (NASDAQ:ELGX) for 6,683 shares. Columbia Wanger Asset Ltd Limited Liability Company reported 3.39M shares. Savings Bank Of Ny Mellon Corp owns 358,079 shares for 0% of their portfolio. Goldman Sachs Group stated it has 242,511 shares.

Investors sentiment decreased to 0.91 in 2017 Q4. Its down 0.59, from 1.5 in 2017Q3. It is negative, as 15 investors sold CRR shares while 40 reduced holdings. 17 funds opened positions while 33 raised stakes. 18.69 million shares or 6.27% less from 19.94 million shares in 2017Q3 were reported. Schroder Invest Management Gp has 0.01% invested in CARBO Ceramics Inc. (NYSE:CRR) for 798,977 shares. 18 are held by Envestnet Asset Mgmt. Invesco Ltd invested in 202,299 shares. Ameriprise Finance Incorporated stated it has 117,755 shares. Barrow Hanley Mewhinney Strauss Limited Liability Company invested 0% of its portfolio in CARBO Ceramics Inc. (NYSE:CRR). Royal Bank & Trust Of Canada reported 28,550 shares or 0% of all its holdings. Oz LP reported 0% stake. Bank & Trust Of Montreal Can holds 18,191 shares. Jpmorgan Chase And Co invested 0% in CARBO Ceramics Inc. (NYSE:CRR). Principal Finance Group Inc invested 0% of its portfolio in CARBO Ceramics Inc. (NYSE:CRR). Comerica Financial Bank reported 0% in CARBO Ceramics Inc. (NYSE:CRR). 175,600 were accumulated by Geode Cap Mngmt Ltd Llc. 269,640 were reported by Northern Trust Corporation. American Group Inc holds 0% or 18,135 shares in its portfolio. 139,069 were accumulated by Parametric Port Associates Lc.

Greatmark Investment Partners Inc increased Biogen Inc (NASDAQ:BIIB) stake by 950 shares to 3,335 valued at $1.06M in 2017Q4. It also upped Alps Etf Tr (AMLP) stake by 100,325 shares and now owns 154,775 shares. Target Corp (NYSE:TGT) was raised too.

Analysts await CARBO Ceramics Inc. (NYSE:CRR) to report earnings on April, 26 before the open. They expect $-0.62 EPS, up 49.18% or $0.60 from last year’s $-1.22 per share. After $-0.65 actual EPS reported by CARBO Ceramics Inc. for the previous quarter, Wall Street now forecasts -4.62% EPS growth.

CARBO Ceramics Inc. (NYSE:CRR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts